Botox Manufacturer: $600 Million Poorer, But closer to New Uses

Allergan, the maker of Botox, will pay $600 million in fines and civil settlements after pleading guilty to marketing their product for uses for which it hasn't been FDA approved. The Justice Department accused Allergan of encouraging doctors to use the powerful neurotoxin through kickbacks and by teaching them how to forge drug reports. "The [...]

Maker of Botox Settles Inquiry on Off-Label Marketing

Allergan agreed to pay $600 million to settle charges that it illegally promoted and sold Botox for unapproved uses.

Botox Maker Allergan Agrees To Pay $600 Million And Pleads Guilty To Misdemeanor

Allergan Inc., the makers of BOTOX (onabotulinumtoxinA) announced that it has agreed to pay US $600 million and to plead guilty to misdemeanor, thus reaching a resolution with the DOJ (US Department of Justice) regarding a previously reported Government investigation into the company's past sales and marketing practices related to specific therapeutic uses of BOTOX. The DOJ had alleged that the ...

Allergan agrees $600m settlement for unapproved Botox marketing

CHICAGO – Allergan Inc has agreed to pay $600 million to settle a federal investigation of its marketing practices for the injectable wrinkle smoother Botox.

Allergan Settles Botox-Related Charges For $600 Million

Allergan Settles Botox-Related Charges For $600 Million

Allergan to pay $600 mn to US government to settle Botox off-label misuse

Allergan, Inc. announced that it has reached a resolution with the United States Department of Justice (DOJ) regarding the previously reported Government investigation into Allergan's past US sales and marketing practices relating to certain therapeutic uses of Botox (onabotulinumtoxinA).